Financial Performance - For the fiscal year ending December 31, 2023, the total revenue was RM 117,797,000, a decrease of 12.2% compared to RM 134,182,000 in 2022[4] - The gross profit for the fiscal year was RM 26,117,000, down 18.4% from RM 31,954,000 in the previous year[4] - The profit before tax was RM 15,024,000, representing a decline of 9.5% from RM 16,593,000 in 2022[4] - The net profit for the fiscal year was RM 11,008,000, slightly down by 2.7% from RM 11,313,000 in 2022[4] - The total comprehensive income for the fiscal year was RM 11,557,000, an increase of 46.5% compared to RM 7,919,000 in the previous year[4] - The gross profit for the animal feed additives segment was 21,008 thousand MYR, while the human food ingredients segment reported a gross profit of 5,109 thousand MYR, totaling 26,117 thousand MYR for 2023[23] - The pre-tax profit for the fiscal year 2023 was 15,024 thousand MYR, down from 16,593 thousand MYR in 2022, representing a decline of 9.5%[32] - The company reported a net profit of 11,008 thousand MYR for 2023, compared to 11,313 thousand MYR in 2022, indicating a decrease of 2.7%[29] - Gross profit decreased from approximately 32.0 million MYR to about 26.1 million MYR, a decline of approximately 18.4%, with the gross profit margin slightly dropping from about 23.8% to approximately 22.2%[60] Assets and Equity - The company's total assets increased to RM 170,511,000 from RM 159,144,000, reflecting a growth of 7.9%[8] - The total equity attributable to the owners of the company rose to RM 160,579,000, up from RM 148,603,000, marking an increase of 8.5%[8] - The company reported a total profit attributable to equity holders of 11,418,000 MYR for 2023, compared to 11,313,000 MYR in 2022[36] - The company's total equity attributable to shareholders increased to approximately 160.6 million MYR from about 148.6 million MYR in the previous year[71] Revenue Breakdown - Distribution revenue from external customers for the animal feed additives segment was 55,429 thousand MYR, while the human food ingredients segment generated 28,064 thousand MYR in 2023[23] - The company’s distribution segment accounted for 70.9% of total revenue in 2023, while manufacturing contributed 29.1%[55] - Manufacturing revenue decreased from approximately 37.7 million MYR to about 34.3 million MYR, a decline of approximately 9.0% or about 3.4 million MYR, primarily due to reduced demand for vitamin and mineral premixes[56] - Distribution revenue fell from approximately 96.4 million MYR to about 83.5 million MYR, a decrease of approximately 13.4% or about 12.9 million MYR, mainly attributed to intense market competition leading to decreased demand for animal feed and human food ingredients[57] Costs and Expenses - The total sales and distribution costs for the fiscal year 2023 amounted to 2,381 thousand MYR, compared to 2,629 thousand MYR in 2022, reflecting a reduction of 9.4%[23] - The total employee costs for 2023 were 6,347 thousand MYR, an increase from 5,851 thousand MYR in 2022[30] - Administrative and other operating expenses rose by approximately 2.4 million MYR or 22.6% to about 13.0 million MYR, mainly due to expenses incurred by a subsidiary's investment in Hainan, China[62] Investments and Financial Position - The company has made a 2,877,000 MYR investment for a 4.8% equity stake in a company registered in Malaysia, completed after the fiscal year-end[45] - The fair value of other investments increased from 30,480,000 MYR in 2022 to 31,769,000 MYR in 2023[47] - The fair value of significant investments in the Affin Hwang Selected Bond Fund was approximately 31.8 million MYR, representing 18.6% of total assets[72] - As of December 31, 2023, a portion of the unutilized net proceeds amounting to $3.0 million (approximately HKD 23.7 million) has been invested in the Affin Hwang selected bond fund[90] Corporate Governance and Management - The company is committed to good corporate governance practices to enhance shareholder value and ensure effective accountability[91] - The roles of the chairman and CEO are currently held by the same individual, which the board believes provides strong and consistent leadership[92] - The company has maintained the minimum public float required by the listing rules since its listing date[110] Future Plans and Considerations - The company plans to consider foreign exchange hedging activities to mitigate currency fluctuations impacting operational performance[81] - The company will continue to monitor the global economy closely and evaluate the appropriate timing for utilizing the unutilized net proceeds[88] - The company has decided to delay the utilization of unutilized net proceeds to minimize potential risks associated with expansion plans[88] Shareholder Information - The company did not declare any dividends for the fiscal year ending December 31, 2023, consistent with the previous year[34] - The company has not recommended the distribution of a final dividend for the current fiscal year, consistent with the previous year[95] - The total number of shares that may be issued under the stock option plan is capped at 50,000,000 shares, subject to shareholder approval for any increase[100] - Each eligible participant's maximum entitlement under the stock option plan is limited to 1% of the company's issued share capital in any 12-month period[101] Meeting and Compliance - The annual general meeting is scheduled for June 26, 2024, with a suspension of share transfer registration from June 21 to June 26, 2024[111][112] - The audit committee has reviewed the consolidated financial statements for the fiscal year and confirmed compliance with applicable accounting standards and listing rules[114][115] - The annual performance announcement and annual report will be published on the company's and the stock exchange's websites, containing all relevant information as required by listing rules[117]

Financial Performance - Revenue for the six months ended June 30, 2023, was RM 59,123,000, a decrease of 18% compared to RM 72,044,000 in the same period of 2022[7] - Gross profit for the same period was RM 12,793,000, down 28% from RM 17,816,000 year-on-year[7] - The company reported a profit attributable to equity holders of RM 5,541,000, a decrease of 14% from RM 6,425,000 in the previous year[7] - Basic and diluted earnings per share for the period were 1.17 sen, compared to 1.36 sen in the prior year[7] - For the six months ended June 30, 2023, total revenue was RM 59,123,000, an increase from RM 41,273,000 in the same period of 2022, representing a growth of 43.3%[24] - The gross profit for the same period was RM 12,793,000, compared to RM 7,817,000 in 2022, reflecting a significant increase of 63.2%[24] - The company reported a pre-tax profit of RM 7,815,000, compared to RM 5,541,000 in the previous year, showing an increase of 41.0%[24] - The company reported a pre-tax profit of 9,726 thousand MYR, down from 10,726 thousand MYR in the previous year, indicating a decline of 9.3%[32] - Net profit for the period was 6,425 thousand MYR, a decrease of 6.5% from 6,425 thousand MYR in the same period of 2022[35] Assets and Equity - Total assets as of June 30, 2023, amounted to RM 165,841,000, an increase from RM 159,144,000 at the end of 2022[9] - Total equity increased to RM 154,920,000 as of June 30, 2023, compared to RM 148,603,000 at the end of 2022[9] - The total equity attributable to owners was approximately 154.9 million MYR as of June 30, 2023, compared to 148.6 million MYR as of December 31, 2022[75] Cash Flow and Financing - Cash generated from operating activities for the six months was RM 13,703,000, significantly higher than RM 7,534,000 in the same period last year[12] - The bank balance and cash at the end of the reporting period was RM 57,280,000, up from RM 22,933,000 in 2022, marking an increase of 149.5%[13] - The net cash used in financing activities was RM (430,000), slightly higher than RM (377,000) in the previous year, indicating a 14.1% increase in cash outflow[13] - The company’s lease liabilities increased to 409 thousand MYR as of June 30, 2023, from 87 thousand MYR as of December 31, 2022[47] - The group had no outstanding bank borrowings as of June 30, 2023, and lease liabilities were approximately 0.4 million MYR[75] Operational Performance - The division performance for animal feed additives generated a profit of RM 9,190,000, while the human food ingredients division contributed RM 2,249,000, totaling RM 11,439,000[24] - Distribution revenue for the same period was 41,273 thousand MYR, down 20% from 51,697 thousand MYR in 2022[30] - Production revenue decreased to 17,850 thousand MYR from 20,347 thousand MYR, representing a decline of 12%[30] - The distribution business generated revenue of approximately MYR 41.3 million, accounting for about 69.8% of total revenue, a decrease of approximately MYR 10.4 million or 20.1% from the previous year[65] - Manufacturing business revenue was approximately MYR 17.9 million, representing about 30.2% of total revenue, a decrease of approximately MYR 2.4 million or 11.8% from the previous year[65] Expenses and Cost Management - The total administrative and other operating expenses were RM (5,530,000), which impacted the overall profitability[24] - Administrative and other operating expenses decreased to approximately MYR 5.5 million, down about 15.4% from approximately MYR 6.5 million in the same period of 2022[70] - The company did not incur any capital expenditures for property, plant, and equipment during the reporting period[24] - Capital expenditures for property, plant, and equipment reached approximately 1,283 thousand MYR, up from 976 thousand MYR in the previous year, reflecting a growth of 31.3%[26] Strategic Initiatives - The company plans to focus on market expansion and new product development to drive future growth[7] - The company continues to focus on expanding its distribution of animal feed additives and human food ingredients in the Malaysian market[16] - The company entered into a cooperation agreement to invest up to RMB 25 million in a development project in Wenchang City, China, as part of its strategy to expand into new markets[59] - The company has adopted a cautious approach to business expansion due to the adverse effects of the COVID-19 pandemic on global growth prospects[92] - The company is actively exploring suitable business and investment opportunities while closely monitoring the global economy[92] Governance and Compliance - The board members collectively control 337.5 million shares, representing 71.5% of the company's total issued share capital[94] - Garry-Worth Investment Limited, controlled by the chairman, holds 53.37% of the shares in the company[95] - The company has adopted the principles of the corporate governance code revised and effective from January 1, 2022, to ensure effective accountability and enhance shareholder value[106] - The roles of the chairman and the CEO are held by the same individual, Datuk Seri Lee Haw Yih, which the board believes provides strong and consistent leadership[108] - The company has maintained compliance with applicable provisions of the corporate governance code during the six months ended June 30, 2023, except for the aforementioned deviation regarding the roles of chairman and CEO[108] Shareholder Information - The company did not declare an interim dividend for the six months ended June 30, 2023, consistent with the previous year[36] - The group did not declare any interim dividends for the six months ended June 30, 2023[78] - The company has adopted a share option scheme approved by shareholders on April 8, 2020, aimed at incentivizing employees and other qualified individuals for their contributions to the group's development[99] - As of June 30, 2023, the total number of shares available for issuance under the share option scheme is 50,000,000, representing approximately 10.6% of the company's total issued share capital[103] Risk Management - The provision for losses on trade receivables increased to 1,304 thousand MYR in 2023 from 1,144 thousand MYR in 2022, indicating a rise in credit risk[39] - The aging analysis of trade receivables shows that 30 days overdue receivables decreased by 16.5% to 8,854 thousand MYR in 2023 from 10,605 thousand MYR in 2022[40] - The company maintains a cautiously optimistic outlook for long-term development while prioritizing prudent financial management and cost control measures[64]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Ritamix Global Limited 利 特 米 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：1936） 截至2023年6月30日止六個月 之中期業績公告 利特米有限公司董事會（分別為「董事會」、「董事」及「本公司」）宣佈本公司及其附屬公司（統稱為 「本集團」）截至2023年6月30日止六個月之未經審核簡明綜合業績，連同2022年同期的相關比較數字 如下： ...

香港交易及結算所有限公司及聯交所對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並 明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Ritamix Global Limited 利 特 米 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：1936） 有關 本公司截至二零二二年十二月三十一日止年度之年度報告 之補充公告 茲提述利特米有限公司（「本公司」，連同其附屬公司統稱「本集團」）日期為二零二零年四月 二十四日的招股章程（「招股章程」）、日期為二零二一年十月四日的公告（「公告」）及本公司 於二零二三年四月二十六日刊發的截至二零二二年十二月三十一日止年度的年度報告（「二 零二二年年報」）。除另有界定者外，本公告所用詞彙與招股章程、公告及二零二二年年報 所界定者具有相同涵義。 所得款項用途 誠如二零二二年年報所披露，經扣除包銷費用、佣金及其他上市開支後，本公司自上市收 取的所得款項淨額約為72.4百萬港元（「所得款項淨額」）。截至二零二二年十二月三十一 日，尚未動用所得款項淨額約為58.4百萬港元（「尚未動用所得款項淨額」）。 根據上市規則附 ...

Financial Performance - The company recorded a revenue of approximately 134.2 million MYR for the fiscal year ending December 31, 2022, an increase of about 11.7% from 120.1 million MYR in the previous fiscal year[12]. - The distribution segment contributed 96.4 million MYR, accounting for 71.9% of total revenue, while the manufacturing segment generated 37.7 million MYR, representing 28.1% of total revenue[19]. - The net profit after tax decreased to approximately 11.3 million MYR, down about 4.2% from 11.8 million MYR in the previous fiscal year, primarily due to unrealized fair value losses on short-term investments[13]. - Earnings per share for the fiscal year were approximately 2.40 sen, compared to 2.41 sen in the previous fiscal year[13]. - Distribution revenue increased from approximately RM 83.4 million for the fiscal year ended December 31, 2021, to approximately RM 96.4 million for the current fiscal year, representing an increase of about 15.6% or RM 13.0 million, primarily due to soaring sales prices of animal feed and human food ingredients[21]. - Gross profit rose from approximately RM 27.9 million for the fiscal year ended December 31, 2021, to approximately RM 32.0 million for the current fiscal year, an increase of about 14.7%, with the gross profit margin slightly improving from approximately 23.2% to about 23.8%[23]. - Other income decreased from approximately RM 2.4 million for the fiscal year ended December 31, 2021, to a loss of approximately RM 2.4 million for the current fiscal year, mainly due to unrealized fair value losses of approximately RM 5.3 million on short-term investments impacted by U.S. Federal Reserve interest rate hikes[24]. - Profit for the fiscal years ended December 31, 2022, and 2021, was approximately RM 11.3 million and RM 11.8 million, respectively, with earnings per share of approximately RM 0.024 and RM 0.0241[28]. - Current ratio improved to 14.5 from 10.8, and quick ratio improved to 10.5 from 6.8 for the fiscal year ended December 31, 2022, compared to the previous year[29]. - The company did not recommend a final dividend for the current fiscal year, consistent with the previous year[32]. - As of December 31, 2022, the company's distributable reserves amounted to approximately MYR 146.0 million, an increase from MYR 138.1 million in the previous year[177]. Business Strategy and Outlook - The company plans to explore new business opportunities and maintain a cautious optimism regarding potential growth in Malaysia and overseas markets[15]. - The company aims to manage cost structures and supply chain disruptions to mitigate adverse impacts on its operations[15]. - The company anticipates Malaysia's GDP growth for 2023 to be between 4% and 5% amid global economic challenges[15]. - The company has been focusing on higher-margin products, particularly in the distribution segment, to optimize and manage resources effectively[11]. - The company’s primary business involves the distribution of animal feed additives and the production of premixes for animal feed, with no significant changes in business nature during the fiscal year[167]. - The company has established strong long-term business relationships with major clients, some lasting over 20 years, providing a competitive advantage for stable recurring business and revenue streams[198]. - The company has developed close long-term partnerships with suppliers, including Fortune 500 companies and one of the largest chemical manufacturers globally, enhancing overall service delivery[198]. Environmental, Social, and Governance (ESG) Initiatives - The company has established an Environmental, Social, and Governance (ESG) working group to coordinate and implement sustainability strategies, reporting satisfactory performance for the fiscal year 2022[67]. - The ESG report outlines the company's sustainable development performance from January 1, 2022, to December 31, 2022, with no reported violations of laws and regulations in Malaysia[67]. - Greenhouse gas emissions totaled 500.9 tons of CO2 equivalent in 2022, an increase from 473.2 tons in 2021[75]. - Energy consumption was recorded at 657,988 kWh in 2022, up from 645,690 kWh in 2021[79]. - Water usage increased to 4,195 cubic meters in 2022 from 2,874 cubic meters in 2021[80]. - The company aims to reduce greenhouse gas emissions density to the lowest possible level[75]. - The company has implemented waste management principles focusing on reduction, reuse, and recycling[78]. - The company continues to monitor its operations for potential environmental impacts and aims to enhance its sustainability practices[78]. - In the fiscal year 2022, the company did not incur any significant environmental violations or penalties from the Malaysian Ministry of Environment[84]. Human Resources and Employee Welfare - The total employee cost for the fiscal year was approximately MYR 5.9 million, down from MYR 6.2 million in the previous year[48]. - The group had 52 employees as of December 31, 2022, compared to 53 in the previous year[48]. - The employee turnover rate was reported at 5.8% for employees under 30 years old, 9.6% for those aged 30 to 50, and 7.7% for employees over 50[90]. - In fiscal year 2022, a total of 15 employees participated in training, with an average training duration of 12 hours per employee[95]. - The company has maintained a zero fatality rate in workplace incidents over the past three years, with no work-related injuries resulting in lost workdays in fiscal year 2022[94]. - The company is committed to providing a safe and healthy work environment, adhering to the Occupational Safety and Health Act of 1994[93]. - Continuous training programs are provided for employees, including safety training and subsidies for confirmed courses, aimed at retaining talented staff[196]. - The company promotes diversity and aims to ensure gender equality in its workforce[87]. Corporate Governance - The company has adopted a corporate governance framework to ensure compliance with good governance practices and stakeholder expectations[107]. - The company has established an Audit Committee, Remuneration Committee, and Nomination Committee to fulfill its governance responsibilities as required by the Listing Rules[112]. - The board of directors is responsible for overseeing the group's business affairs and overall performance management, ensuring necessary financial and human resources support[111]. - The company has implemented mechanisms to ensure the board receives independent opinions and advice, maintaining high independence[123]. - The company has adopted an anti-bribery and corruption policy, emphasizing integrity and zero tolerance towards any form of bribery[124]. - The board consists of six members, including three independent non-executive directors, meeting the requirement of at least one-third being independent[119]. - The company has received ISO 9001:2015 certification for several subsidiaries, ensuring quality management standards are met[101]. Risk Management - The company has implemented risk management policies to address various risks, including environmental, social, and governance risks, to avoid potential financial or reputational damage[150]. - An independent internal control consultant was hired to review the financial procedures and internal control systems, confirming their effectiveness[151]. - The board is responsible for overseeing the company's strategic development and setting appropriate risk management policies to achieve strategic goals[155]. Shareholder Communication and Policies - The company is committed to providing balanced and easily understandable information to shareholders and stakeholders through various communication channels[161]. - The company’s articles of association have been revised and are available for review on the company and stock exchange websites[162]. - The company’s dividend policy is discretionary and subject to various factors, with no guarantee of future dividends[164]. - Shareholders can request a special general meeting if they hold at least 10% of the voting rights and must submit a written request to the board[157]. Capital Management - The company has allocated HKD 3.6 million for general working capital, which has been fully utilized[52]. - The company has not entered into any capital-linked agreements that would lead to the issuance of shares during the fiscal year[188]. - The maximum number of shares that can be issued under the share option plan is capped at 50,000,000 shares, representing approximately 10.6% of the total issued share capital as of December 31, 2022[187].

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致 的任何損失承擔任何責任。 Ritamix Global Limited 利 特 米 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：1936） 截至二零二二年十二月三十一日止財政年度 之年度業績公告 利特米有限公司（「本公司」）董事（「董事」）會（「董事會」）宣佈本公司及其附屬公司（統稱為 「本集團」）截至二零二二年十二月三十一日止財政年度之經審核綜合業績，連同截至二零 二一年十二月三十一日止財政年度的相關比較數字如下： ...

Financial Performance - Revenue for the six months ended June 30, 2022, was RM 72,044,000, representing a 27% increase from RM 56,772,000 in the same period of 2021[7] - Gross profit for the same period was RM 17,816,000, up 33% from RM 13,382,000 in 2021[7] - Profit before tax increased to RM 9,726,000, a 19% rise compared to RM 8,164,000 in the previous year[7] - Net profit attributable to equity holders for the period was RM 6,425,000, which is a 10% increase from RM 5,829,000 in 2021[7] - Total comprehensive income for the period was RM 7,207,000, compared to RM 6,791,000 in the same period last year, reflecting a 6% increase[7] - Total revenue for the animal feed additives segment was 55,584 thousand MYR, while the human food ingredients segment generated 16,460 thousand MYR, leading to a total revenue of 72,044 thousand MYR[38] - The distribution revenue reached 51,697 thousand MYR, up from 40,262 thousand MYR in the previous year, marking a growth of 28%[62] - The production revenue also increased to 20,347 thousand MYR from 16,510 thousand MYR, which is a growth of 23%[62] - The gross profit for the six months ended June 30, 2022, was 13,382 thousand MYR, compared to 10,109 thousand MYR in the same period of 2021, indicating a growth of 32%[62] Assets and Liabilities - Current assets as of June 30, 2022, amounted to RM 129,525,000, an increase from RM 122,451,000 at the end of 2021[9] - Total assets less current liabilities stood at RM 148,498,000, up from RM 141,326,000 at the end of 2021[9] - The company’s total equity as of June 30, 2022, was RM 147,891,000, compared to RM 140,684,000 at the end of 2021[9] - As of June 30, 2022, total trade receivables amounted to 33,784 thousand MYR, an increase from 26,909 thousand MYR as of December 31, 2021, representing a growth of approximately 25.5%[76][83] - The company’s total liabilities decreased from 12,153 thousand MYR as of December 31, 2021, to 10,859 thousand MYR as of June 30, 2022, indicating a reduction of about 10.7%[86] Cash Flow - Cash and cash equivalents increased significantly to RM 22,933,000 from RM 11,666,000 at the end of 2021[9] - Operating cash flow before changes in working capital increased to 13,542 thousand MYR, up from 8,996 thousand MYR, indicating a growth of approximately 50.3%[17] - The net cash generated from operating activities was 7,534 thousand MYR, a decrease from 9,760 thousand MYR, reflecting a decline of about 22.5%[17] - The company experienced a significant increase in cash and cash equivalents, rising to 22,933 thousand MYR at the end of the reporting period from 11,666 thousand MYR at the beginning, marking an increase of approximately 96.5%[19] Expenses - The total administrative and other operating expenses were 6,516 thousand MYR, which is an increase from the previous year's 5,042 thousand MYR[47] - The effective tax expense for the period was 3,301 thousand MYR, up from 2,335 thousand MYR in the previous year, reflecting an increase of 41%[67] - The financing costs for the period were 18 thousand MYR, a slight increase from 24 thousand MYR in the previous year[48] - The depreciation for the period was approximately 912 thousand MYR, compared to 751 thousand MYR in the same period of 2021[65] Shareholder Information - As of June 30, 2022, the company had 472,000,000 issued and fully paid shares, down from 500,000,000 at the beginning of the year, following the cancellation of 28,000,000 shares[92] - The major shareholders collectively control 337.5 million shares, representing 71.5% of the company's total issued share capital[162] - Garry-Worth Investment Limited is the beneficial owner of 337.5 million shares, with a 53.37% interest held by the chairman and executive director[163] - The company has adopted a share option scheme allowing the board to grant options to qualified individuals, with a total of 50,000,000 shares available for issuance, representing approximately 10.6% of the total issued share capital as of June 30, 2022[172][176] Corporate Governance - The board of directors confirmed compliance with the standards set out in the corporate governance code during the six months ending June 30, 2022[178][179] - The company has established an audit committee to oversee financial reporting and internal controls, consisting of three independent non-executive directors[182] - The chairman and CEO roles are held by the same individual, which the board believes is appropriate under the current circumstances[179] Future Plans and Investments - The company plans to gradually utilize the net proceeds to strengthen its business growth following Malaysia's transition to an endemic phase of COVID-19 on April 1, 2022[160] - The company has established a centralized enterprise resource planning system with an investment of $3.7 million, completed by December 31, 2022[159] - The company has allocated $1.7 million for sales and marketing activities, with $1.6 million yet to be utilized[159] - The company has set up new testing laboratories with an investment of $3.5 million, completed by June 30, 2023[159]

Financial Performance - The company's revenue increased by approximately 3.7% from about MYR 115.9 million in the previous fiscal year to approximately MYR 120.1 million in the current fiscal year[20] - Profit for the fiscal years ended December 31, 2020, and December 31, 2021, was approximately MYR 8.5 million and MYR 11.8 million, respectively[22] - Earnings per share for the fiscal years ended December 31, 2020, and December 31, 2021, were approximately MYR 0.0186 and MYR 0.0241, respectively[22] - The group's revenue increased by approximately 3.7% from about 115.9 million MYR in the year ended December 31, 2020, to approximately 120.1 million MYR in the current fiscal year[28] - The group's profit for the year was approximately 11.8 million MYR, compared to approximately 8.5 million MYR in the previous year, with earnings per share increasing from approximately 1.86 MYR to about 2.41 MYR[38] Business Strategy and Operations - The company plans to explore various business opportunities to promote growth in response to market conditions[18] - The company focuses on adjusting pricing and emphasizing higher-margin products to maintain revenue growth[18] - The distribution segment was only slightly affected by COVID-19, while the production segment faced operational disruptions due to global supply chain issues[20] - The company implemented strict COVID-19 preventive measures, including mandatory testing and frequent disinfection of facilities[19] - The group is actively exploring opportunities in Malaysia and overseas as it adapts to the new normal post-COVID-19[24] Revenue Segmentation - The manufacturing segment's revenue decreased by about 5.8% from approximately 39.1 million MYR to approximately 36.8 million MYR due to intensified market competition and supply chain issues caused by COVID-19[29] - The distribution segment's revenue increased by approximately 8.5% from about 76.8 million MYR to approximately 83.4 million MYR, primarily due to an increase in sales of tea by about 4.4 million MYR[30] Expenses and Costs - Administrative and other operating expenses increased from approximately 9.8 million MYR to approximately 11.4 million MYR, mainly due to product registration fees, employee costs, and professional consulting fees[36] - Financing costs recorded were approximately 31,000 MYR and approximately 50,000 MYR for the years ended December 31, 2021, and 2020, respectively[37] Liquidity and Financial Position - The current ratio was reported at 10.8, while the quick ratio was at 6.8, indicating a strong liquidity position[39] - The group did not recommend a final dividend for the current fiscal year, consistent with the previous year[47] Investments and Assets - The total assets measured at fair value through profit or loss amounted to 43,336,000 MYR as of December 31, 2021, compared to 53,074,000 MYR in the previous year[53] - The significant investments included Affin Hwang Aiiman Money Market Fund with a fair value of 19,210,000 MYR, and Affin Hwang Selected Bond Fund with a fair value of 20,219,000 MYR, reflecting a 27% return[53] - The company made a strategic investment of 1.0 million USD (approximately 7.8 million HKD) to acquire a 6.67% stake in VetCell International Limited, focusing on long-term strategic purposes[56] - The group has a capital commitment of 25,500,000 RMB (approximately 16,641,000 MYR) related to its investment in Hainan[58] Risk Management - The company has identified key risks including fluctuations in product demand and potential disruptions in the supply of raw materials, which could adversely affect financial performance[64] - The group plans to monitor foreign currency risks and may consider foreign exchange hedging activities to mitigate the impact of currency fluctuations on operational performance[68] - The company did not utilize any derivative financial instruments during the fiscal year to manage foreign currency risks[68] Employee and Workforce - As of December 31, 2021, the group had 53 employees, with total employee costs (including directors' remuneration) amounting to approximately MYR 6.1 million, an increase from MYR 5.5 million in 2020[69] - The workforce consists of 53 full-time employees, with 53% male and 47% female representation[126] - Over 25 employees participated in training programs during the fiscal year, averaging 7 hours of training per employee[132] - The company has not employed any children or adolescents under 18 years of age and has no reported cases of forced labor[133] Environmental Impact - In the fiscal year 2021, the total greenhouse gas emissions amounted to 599.0 tons of CO2 equivalent, an increase from 447.7 tons in 2020, representing a 33.8% rise[104] - The company reported nitrogen oxides (NOx) emissions of 0.9 kg in 2021, up from 0.4 kg in 2020, indicating a 125% increase[102] - Diesel consumption decreased to 60,241 liters in 2021 from 72,729 liters in 2020, reflecting a reduction of 17.2%[109] - The electricity consumption was recorded at 457,589 kWh in 2021, down from 574,023 kWh in 2020, showing a decrease of 20.3%[109] - The company has established environmental policies to minimize negative impacts on the environment, adhering to the Malaysian Environmental Quality Act since 1974[112] Corporate Governance - The board of directors is responsible for overseeing the company's business affairs and overall performance management[143] - The company has adopted corporate governance codes and principles to enhance shareholder value and ensure accountability[141] - The company has established an audit committee to oversee compliance with legal and regulatory requirements[143] - The company has implemented risk management policies to address potential risks, including national, regulatory, and operational risks[199] - The company has established three board committees: Audit Committee, Remuneration Committee, and Nomination Committee to oversee specific areas of governance[174] Community Engagement - The company aims to continue engaging with and contributing to the communities where it operates in the future[139] - The company made cash and in-kind donations of approximately 21,000 MYR in fiscal year 2021, a decrease from about 61,000 MYR in fiscal year 2020[139] - The company supports local employment in the regions where it operates[122]

Financial Performance - Revenue for the six months ended June 30, 2021, was RM 56,772,000, a decrease of 3.1% compared to RM 58,573,000 for the same period in 2020[10]. - Gross profit for the same period was RM 13,382,000, slightly up from RM 13,256,000 in 2020, indicating a marginal increase of 0.9%[10]. - Profit before tax increased significantly to RM 8,164,000, up 58.9% from RM 5,138,000 in the previous year[10]. - Net profit attributable to equity holders for the period was RM 5,829,000, compared to RM 2,828,000 in 2020, representing a growth of 106.5%[10]. - Total comprehensive income for the period was RM 6,791,000, a substantial increase from RM 1,741,000 in the same period last year[10]. - The company reported a basic and diluted earnings per share of 1.17 sen, compared to 0.69 sen in the previous year, marking an increase of 69.6%[10]. - For the six months ended June 30, 2021, the company reported a profit of 5,829 thousand MYR, compared to 2,828 thousand MYR for the same period in 2020, representing a 106% increase[16]. - The total comprehensive income for the six months ended June 30, 2021, was 6,791 thousand MYR, up from 1,741 thousand MYR in the previous year, indicating a significant growth of 289%[16]. Cash Flow and Assets - Cash and cash equivalents increased to RM 28,776,000 from RM 15,171,000, showing a growth of 89.9%[12]. - Current assets net worth stood at RM 133,424,000, up from RM 126,624,000, reflecting a growth of 5.6%[12]. - Total assets less current liabilities increased to RM 148,144,000 from RM 141,349,000, indicating a growth of 4.0%[12]. - The operating cash flow before changes in working capital for the six months ended June 30, 2021, was 8,996 thousand MYR, compared to 4,647 thousand MYR in 2020, reflecting an increase of 93%[19]. - The net cash generated from operating activities for the six months ended June 30, 2021, was 9,760 thousand MYR, a substantial rise from 2,477 thousand MYR in the same period last year, marking a 294% increase[19]. - The company’s cash and cash equivalents at the end of the reporting period were 28,776 thousand MYR, compared to 36,864 thousand MYR at the end of the previous year, showing a decrease of 22%[22]. Revenue Breakdown - Total revenue for the six months ended June 30, 2021, was RM 56,772 thousand, a decrease of 3% from RM 58,573 thousand for the same period in 2020[96]. - Distribution revenue increased to RM 40,262 thousand, up 9% from RM 37,046 thousand in the previous year[96]. - Production revenue decreased to RM 16,510 thousand, down 23% from RM 21,527 thousand in the same period last year[96]. - The decrease in manufacturing revenue was primarily due to a reduction of approximately 3.7 million MYR in sales of vitamin premixes to overseas customers[173]. - The increase in distribution revenue was mainly driven by a rise in sales of health products, particularly a tea product launched in December 2020, which saw an increase of approximately 3.0 million MYR[175]. Expenses and Costs - Total employee costs decreased to RM 2,763,000 in 2021 from RM 2,822,000 in 2020, a reduction of 2.1%[99]. - The total tax expense for the six months ended June 30, 2021, was RM 2,335,000, slightly higher than RM 2,310,000 in 2020, an increase of 1.1%[101]. - The total depreciation expense for the six months ended June 30, 2021, was RM 751,000, compared to RM 632,000 in 2020, an increase of 18.8%[99]. - Sales and distribution costs increased to approximately 1.2 million MYR, an increase of about 0.1 million MYR or 10.0% compared to 1.1 million MYR in the same period last year, primarily due to marketing activities for the newly launched tea[178]. - Administrative and other operating expenses rose to approximately 5.0 million MYR, an increase of about 1.1 million MYR or 30.6% from 3.9 million MYR in the previous year, mainly due to increased professional fees for compliance purposes post-IPO and foreign exchange losses[179]. Strategic Focus and Future Outlook - The company continues to focus on expanding its market presence and enhancing product offerings to drive future growth[10]. - The company plans to continue focusing on its core segments of animal feed additives and human food ingredients for future growth[32]. - The company is actively exploring new growth and expansion opportunities both locally and internationally in response to the pandemic[172]. - The company’s wholly-owned subsidiary entered into a cooperation agreement with a health biotechnology company, establishing a new indirect subsidiary in Hainan[172]. - The company believes that the pandemic will soon be well-controlled, allowing for smoother economic activities[172]. Shareholder Returns - The company did not declare an interim dividend for the six months ended June 30, 2021, consistent with the previous year[108]. - The board of directors decided not to declare any interim dividend for the six months ended June 30, 2021, consistent with the previous year[195].

RITAMIX GLOBAL LIMITED 利特米有限公司 (於開曼群島註冊成立的有限公司) 股份代號：1936 2020年報 A 00 錄 | --- | --- | |--------------------------|-------| | 公司资料 | | | 主席致辭 | | | 管理層討論及分析 | | | 董事及高級管理層履歷詳情 | | | 環境·社會與管治報告 | | | 企業管治報告 | | | 董事會報告 | | | 獨立聯席核數師報告 | | | 综合損益及其他全面收益表 | | | 綜合財務狀況表 | | | 綜合權益變動表 | | | 綜合現金流量表 | | | 綜合財務報表附註 | | | 四年財務摘要 | | 02 04 06 13 l ୧ 23 36 46 5 I 52 54 55 57 I02 利特米有限公司 年度報告2020 0 I 公司資料 Ng Siok Hui 女士 Lim Chee Hoong 先生 31 樓 合規顧問 薪酬委員會 註冊辦事處 Windward 3, Regatta Office Park PO Box 1350 Grand Cayman KY1 ...